Showing 20 of 55 recruiting trials for “embryonal-carcinoma”
Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
👨⚕️ Suzette Delaloge, MD, Gustave Roussy, Veillejuif, France📍 1 site📅 Started Mar 2026View details ↗
Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Retifanlimab and Ruxolitinib In Solid Malignancies
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
Enrolling by InvitationNCT06885424 ↗
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC
68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
RecruitingNCT06955910 ↗
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
👨⚕️ Roberto Iacovelli, M.D.; Ph.D., Catholic University of Rome, Italy📍 1 site📅 Started Jun 2025View details ↗
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
🏥 AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT06916624 ↗
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
RecruitingNCT07024680 ↗
Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
👨⚕️ Siddharth A Padia, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Dec 2024View details ↗
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →